Csilla Fazakas

Dr. Csilla Fazakas


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
KMKinga Molnár
Kinga Molnár
Bálint LőrincziBálint Lőrinczi
Bálint Lőrinczi
CFCsilla Fazakas
Csilla Fazakas
István SzatmáriIstván Szatmári
István Szatmári
FFFerenc Fulop
Ferenc Fulop
László VécseiLászló Vécsei
László Vécsei
By being an antagonist of glutamate and other receptors, kynurenic acid serves as an endogenous neuroprotectant in several pathologies of the brain. Unfortunately, systemic administration of kynurenic acid is hindered by its low permeability through the blood–brain barrier. One possibility to overcome this problem is to use analogues with similar biological activity as kynurenic acid, but with an increased permeability through the blood–brain barrier. We synthesized six novel aminoalkylated amide derivatives of kynurenic acid, among which SZR-104 (N-(2-(dimethylamino)ethyl)-3-(morpholinomethyl)-4-hydroxyquinoline-2-carboxamide) proved to have the highest permeability through an in vitro blood–brain barrier model. In addition, permeability of SZR-104 was significantly higher than that of kynurenic acid, xanthurenic acid and 39B, a quinolone derivative/xanthurenic acid analogue. Since peripherally administered SZR-104 is able to inhibit epileptiform activity in the brain, we conclude that SZR-104 is a promising kynurenic acid analogue with good penetrability into the central nervous system.

Verified
Journal Article
Open access
PDF file
MKMihály Kozma
Mihály Kozma
MÁMészáros Ádám
Mészáros Ádám
ÁNÁdám Nyúl-Tóth
Ádám Nyúl-Tóth
KMKinga Molnár
Kinga Molnár
LCLaura Costea
Laura Costea
IKIstván A. Krizbai
István A. Krizbai
By upregulation of cell adhesion molecules and secretion of proinflammatory cytokines, cells of the neurovascular unit, including pericytes and endothelial cells, actively participate in neuroinflammatory reactions. As previously shown, both cell types can activate inflammasomes, cerebral endothelial cells (CECs) through the canonical pathway, while pericytes only through the noncanonical pathway. Using complex in vitro models, we demonstrate here that the noncanonical inflammasome pathway can be induced in CECs as well, leading to a further increase in the secretion of active interleukin-1β over that observed in response to activation of the canonical pathway. In parallel, a more pronounced disruption of tight junctions takes place. We also show that CECs respond to inflammatory stimuli coming from both the apical/blood and the basolateral/brain directions. As a result, CECs can detect factors secreted by pericytes in which the noncanonical inflammasome pathway is activated and respond with inflammatory activation and impairment of the barrier properties. In addition, upon sensing inflammatory signals, CECs release inflammatory factors toward both the blood and the brain sides. Consequently, CECs activate pericytes by upregulating their expression of NLRP3 (NOD-, LRR-, and pyrin domain-containing protein 3), an inflammasome-forming pattern recognition receptor. In conclusion, cerebral pericytes and endothelial cells mutually activate each other in inflammation.

17 July 2019 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
EFEszter Fabian
Eszter Fabian
DRDora Reglodi
Dora Reglodi
GHGabriella Horvath
Gabriella Horvath
BOBalazs Opper
Balazs Opper
GTGabor Toth
Gabor Toth
IKIstván A. Krizbai
István A. Krizbai

28 February 2026 in Biomolecules
Verified
Journal Article
Open access
PDF file
TSTejal Shreeya
Tejal Shreeya
ZHZsófia R. Hernádi
Zsófia R. Hernádi
ZBZsolt Kristóf Bali
Zsolt Kristóf Bali
NBNóra Bruszt
Nóra Bruszt
HIHernadi Istvan
Hernadi Istvan
AFAttila Farkas
Attila Farkas
Background: Traumatic brain injury (TBI) frequently leads to long-term neurological deficits. Recent research also implicates cellular senescence—a state of permanent cell cycle arrest driven by DNA damage—as a key contributor to neuroinflammation and cognitive decline. This study investigates the cell-type specificity of senescence within glial and vascular cells of the neurovascular unit (NVU) following experimental TBI in a rat model. Methods: Rats underwent various TBI scenarios, including single severe TBI (sTBI), single mild TBI (mTBI), repetitive mild TBI (rmTBI) and repetitive sham-operated control (rSham). Twenty-four hours or four weeks later, brains were harvested and brain sections were co-stained for γH2AX and cell type-specific markers. Immunofluorescence microscopy was used to comprehensively assess senescence in both glial and vascular cells of the NVU, specifically astrocytes, microglia, endothelial cells, and pericytes. Results: We observed acute increased astrocyte senescence in sTBI samples and microglial senescence in mTBI and sTBI samples in the neocortex, while endothelial cell senescence was significantly elevated in the neocortex of the sTBI group after four weeks. Pericytes did not exhibit significant signs of senescence at either time point. Conclusion: These findings demonstrate differential γH2AX labelling of NVU components following TBI, suggesting that vulnerability to TBI-induced senescence can be specific both to the cell type and the time after the injury. This has implications on therapies targeting senescent cells for mitigating the long-term consequences of TBI.

5 November 2023 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
IKIstván A. Krizbai
István A. Krizbai
AMAdam Meszaros
Adam Meszaros
KMKinga Molnár
Kinga Molnár
CFCsilla Fazakas
Csilla Fazakas
ALAdel Luvi
Adel Luvi
Imola WilhelmImola Wilhelm
Imola Wilhelm

28 January 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
CFCsilla Fazakas
Csilla Fazakas
AVAttila G. Végh
Attila G. Végh
TDTamás Dudás
Tamás Dudás
DVDorina Varga
Dorina Varga
ALAdél Lüvi
Adél Lüvi
Imola WilhelmImola Wilhelm
Imola Wilhelm
Brain metastases are a common and often fatal complication of certain cancer types, such as triple-negative breast cancer. However, the molecular pathways driving brain metastasis formation, including the migration of cancer cells from the bloodstream to the brain parenchyma across the blood–brain barrier, are not yet fully defined. Therefore, using highly relevant mouse and human model systems, the mechanisms by which triple-negative breast cancer cells and their released extracellular vesicles modulate the blood–brain barrier-forming endothelium to increase its permissiveness to tumour cell entry into the brain are investigated. It is observed that extracellular vesicles derived from tumour cells are taken up by cerebral endothelial cells, where they induce miR-146a-5p- and TGF-β1-mediated downregulation of PAQR5/mPRγ, a membrane progesterone receptor. This, in turn, leads to disruption of interendothelial tight junctions, particularly through repression of claudin-5 expression, a critical protein for maintaining barrier function. Altogether this identifies a novel mechanism by which triple-negative breast cancer-derived extracellular vesicles compromise blood–brain barrier integrity, thereby facilitating transendothelial migration of cancer cells and promoting brain metastasis development. Moreover, this study is the first to highlight the role of membrane progesterone receptors in regulating the blood–brain barrier. Table of contents: Extracellular vesicles from triple-negative breast cancer cells induce miR-146a-5p- and TGF-β1-mediated downregulation of PAQR5/mPRγ, a membrane progesterone receptor, in blood–brain barrier-forming endothelial cells. This results in disruption of interendothelial tight junctions, thereby promoting enhanced migration of cancer cells into the brain. This mechanism highlights the role of membrane progesterone receptors in regulating the blood–brain barrier.